RealSeq Biosciences
PrivateLast Round
Grant
Sep 17, 2025
Total Funding Raised
$9.3M
Company Overview
RealSeq Biosciences is a biotechnology company that develops RNA fragmentomics technology for real-time disease detection, biomarker discovery, and liquid biopsy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RealSeq Biosciences Comparables
Compare RealSeq Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SomaGenics, Inc. | 89% | |
| Exai Bio | 78% | |
| Alithea Genomics | 77% |
RealSeq Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 17, 2025 | ||||
| Grant | Aug 15, 2025 | ||||
| Seed | Mar 1, 2024 | ||||
| Grant | Oct 9, 2023 | ||||
| Seed | Jul 28, 2023 |
Key People
Founding team and executive leadership
RealSeq Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chemical Angel Network | Seed |
| NIH RADx | Grant |
| Santa Clara Ventures | Seed |
| Santa Cruz Ventures | Seed |
| TiE SoCal Angels | Seed |
| MEDA Angels | Seed |
| TiE SoCal Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2025
$2M grant awarded by the National Institutes of Health.
- Jul 28, 2023
$5M raised led by TCA Venture Group and Tech Coast Angels.
RealSeq Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RealSeq Biosciences's valuation, stock price, and market status.
Is RealSeq Biosciences a public or private company?
RealSeq Biosciences is a private company.
What is the current stock price of RealSeq Biosciences?
RealSeq Biosciences is a private company, so its shares have no public market price. Caplight tracks RealSeq Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RealSeq Biosciences worth (valuation)?
Valuation information for RealSeq Biosciences is not publicly available.
Can I buy RealSeq Biosciences stock?
RealSeq Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RealSeq Biosciences's last funding round?
RealSeq Biosciences's most recent funding round was Grant on September 17, 2025.
Who are the main investors in RealSeq Biosciences?
Key investors in RealSeq Biosciences include Santa Clara Ventures, Santa Cruz Ventures, TCA Venture Group, Tech Coast Angels Orange County, Charleston Angel Partners.
Will RealSeq Biosciences IPO soon?
No public IPO plans have been announced for RealSeq Biosciences.
How can I track RealSeq Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in RealSeq Biosciences's shares on secondary markets.